International Journal of Clinical Pediatric Dentistry

Register      Login

SEARCH WITHIN CONTENT

FIND ARTICLE

Volume / Issue

Online First

Archive
Volume  18 (2025)
Volume  17 (2024)
Volume  16 (2023)
Volume  15 (2022)
Volume  14 (2021)
Volume  13 (2020)
Volume  12 (2019)
Volume  11 (2018)
Volume  10 (2017)
Volume  9 (2016)
Volume  8 (2015)
Volume  7 (2014)
Volume  6 (2013)
Volume  5 (2012)
Volume  4 (2011)
Volume  3 (2010)
Volume  2 (2009)
Volume  1 (2008)
Related articles

VOLUME 17 , ISSUE 5 ( May, 2024 ) > List of Articles

CASE REPORT

Radiographic Evaluation of Reparative Dentin Formation after Direct Pulp Capping Using Rosuvastatin vs Mineral Trioxide Aggregate on Young Mature Permanent Molar—90 Days of Follow-up: A Split-mouth Study

Abhinandan Patra, Sonal Gupta, Asmita Das, Rohan Shrivastava

Keywords : Case report, Dentinal bridge, Mineral trioxide aggregate, Pulp-dentin complex, Rosuvastatin

Citation Information : Patra A, Gupta S, Das A, Shrivastava R. Radiographic Evaluation of Reparative Dentin Formation after Direct Pulp Capping Using Rosuvastatin vs Mineral Trioxide Aggregate on Young Mature Permanent Molar—90 Days of Follow-up: A Split-mouth Study. Int J Clin Pediatr Dent 2024; 17 (5):605-611.

DOI: 10.5005/jp-journals-10005-2844

License: CC BY-NC 4.0

Published Online: 22-08-2024

Copyright Statement:  Copyright © 2024; The Author(s).


Abstract

Direct pulp capping (DPC) includes covering the exposed pulp with a medication, dressing, or dental material to preserve its vitality. The idea behind this method of therapy is to induce the pulp to start a dentin bridge, “walling” the exposed site in the process. The most effective dental material to heal exposed pulp is calcium hydroxide. Mineral trioxide aggregate (MTA) causes the formation by causing cytologic and functional alterations in pulpal cells. Rosuvastatin shows pleiotropic effects like increased odontoblastic differentiation, increased mineralization, proliferation of odontoblasts, and induction of angiogenesis. Thus, the aim of the present study is to investigate pulp-dentin complex reactions following DPC with rosuvastatin vs MTA as pulp-capping materials in permanent human molars.

HTML PDF Share
  1. Huang GT. Dental pulp and dentin tissue engineering and regeneration: advancement and challenge. Front Biosci (Elite Ed) 2011;3(2):788–800. DOI: 10.2741/e286
  2. Varalakshmi PR, Kavitha M, Govindan R, et al. Effect of statins with α-tricalcium phosphate on proliferation, differentiation, and mineralization of human dental pulp cells. J Endod 2013;39(6):806–812. DOI: 10.1016/j.joen.2012.12.036
  3. Cox CF, Sübay RK, Ostro E, et al. Tunnel defects in dentin bridges: their formation following direct pulp capping. Operative Dent 1996;21(1):4–11.
  4. Moghaddame-Jafari S, Mantellini MG, Botero TM, et al. Effect of ProRoot MTA on pulp cell apoptosis and proliferation in vitro. J Endod 2005;31(5):387–391. DOI: 10.1097/01.don.0000145423.89539.d7
  5. Yasuda Y, Ogawa M, Arakawa T, et al. The effect of mineral trioxide aggregates on the mineralization ability of rat dental pulp cells: an in vitro study. J Endod 2008;34(9):1057–1060. DOI: 10.1016/j.joen.2008.06.007
  6. Fajardo ME, Rocha ML, Sanchez Marin FJ, et al. Effect of atorvastatin on chronic periodontitis: a randomized pilot study. J Clin Periodontol 2010;37:1016–1022. DOI: 10.1111/j.1600-051X.2010.01619.x
  7. Du Z, Chen J, Yan F, et al. The effects of Simvastatin on bone healing around titanium implants in osteoporotic rats. Clin Oral Impl Res 2009;20(2):145–150. DOI: 10.1111/j.1600-0501.2008.01630.x
  8. Okamoto Y, Sonoyama W, Ono M, et al. Simvastatin induces the odontogenic differentiation of human dental pulp stem cells in vitro and in vivo. J Endod 2009;35(3):367–372. DOI: 10.1016/j.joen.2008.11.024
  9. Min KS, Lee YM, Hong SO, et al. Simvastatin promotes odontoblastic differentiation and expression of angiogenic factors via heme oxygenase-1 in primary cultured human dental pulp cells. J Endod 2010;36(3):447–452. DOI: 10.1016/j.joen.2009.11.021
  10. Gautam K, Kapoor A, Mathur S, et al. Comparative evaluation of autogenous bone graft and autologous platelet-rich fibrin with and without 1.2 mg in situ rosuvastatin gel in the surgical treatment of intrabony defect in chronic periodontitis patients. Contemp Clin Dent 2022;13(1):69–77. DOI: 10.4103/ccd.ccd_740_20
  11. Kalani MM, Nourmohammadi J, Negahdari B, et al. Electrospun core-sheath poly(vinyl alcohol)/silk fibroin nanofibers with Rosuvastatin release functionality for enhancing osteogenesis of human adipose-derived stem cells. Mater Sci Eng C Mater Biol Appl 2019;99:129–139. DOI: 10.1016/j.msec.2019.01.100
  12. Lee Y, Schmid MJ, Marx DB, et al. The effect of local simvastatin delivery strategies on mandibular bone formation in vivo. Biomaterials 2008;29:1940–1999. DOI: 10.1016/j.biomaterials.2007.12.045
  13. Chak RK, Singh RK, Mutyala J, et al. Clinical radiographic evaluation of 3Mixtatin and MTA in primary teeth pulpotomies: a randomized controlled trial. Int J Clin Pediatr Dent 2022;15(S-1):S80–S86. DOI: 10.5005/jp-journals-10005-2216
  14. Ahn KS, Sethi G, Chaturvedi MM, et al. Simvastatin, 3-hydroxy-3-methylglutaryl coenzyme A reductase inhibitor, suppresses osteoclastogenesis induced by receptor activator of nuclear factor-kappaB ligand through modulation of NF-kappaB pathway. Int J Cancer 2008;123:1733–1740. DOI: 10.1002/ijc.23745
  15. Parisay I, Qeidari A, Sabouri E, et al. Cytotoxicity and induced apoptosis of a new bioceramic cement containing simvastatin on stem cells from human exfoliated deciduous teeth. Dent Res J (Isfahan) 2022;19:79.
  16. Bellosta S, Ferri N, Bernini F, et al. Non lipid related effects of statins. Ann Med 2000;32:164–176.
  17. Kida D, Zakrzewska A, Zborowski J, et al. Polymer-based carriers in dental local healing-review and future challenges. Materials 2021;14:3948. DOI: 10.3390/ma14143948
  18. Asl Aminabadi N, Maljaei E, Erfanparast L, et al. Simvastatin versus calcium hydroxide direct pulp capping of human primary molars: a randomized clinical trial. J Dent Res Dent Clin Dent Prospects 2013;7(1):8–14. DOI: 10.5681/joddd.2013.002
  19. Accorinte MLR, Loguercio AD, Reis A, et al. Evaluation of two mineral trioxide aggregate compounds as pulp-capping agents in human teeth. Int Endod J 2009;42:122–128. DOI: 10.1111/j.1365-2591.2008.01485.x
  20. Gutierrez GE, Lalka D, Garrett IR, et al. Transdermal application of lovastatin to rats causes profound increases in bone formation and plasma concentrations. Osteoporos Int 2006;17:1033–1042. DOI: 10.1007/s00198-006-0079-0
  21. Cruz EV, Kota K, Huque J, et al. Penetration of propylene glycol into dentine. Int Endod J 2002;35(4):330–336. DOI: 10.1046/j.1365-2591.2002.00482.x
  22. Aripirala M, Bansal K, Mathur VP, et al. Comparative evaluation of diode laser and simvastatin gel in pulpotomy of primary molars: a randomized clinical trial. J Indian Soc Pedod Prev Dent 2021;39(3):303. DOI: 10.4103/jisppd.jisppd_60_21
  23. Tziafas D, Pantelidou O, Alvanou A, et al. The dentinogenic effect of mineral trioxide aggregate (MTA) in short-term capping experiments. Int Endod J 2002;35:245–254. DOI: 10.1046/j.1365-2591.2002.00471.x
  24. Dammaschke T, Wolff P, Sagheri D, et al. Mineral trioxide aggregate for direct pulp capping: a histologic comparison with calcium hydroxide in rat molars. Quintessence Int 2010;41(2):20–30.
  25. Rao M, Narayana V, Prasad BK, et al. Recent advances in biomimetic materials used in restorative dentistry: an updated review. 2022.
  26. Ding ZY, Tan Y, Peng Q, et al. Novel applications of platelet concentrates in tissue regeneration. Exp Ther Med 2021;21(3):226. DOI: 10.3892/etm.2021.9657
  27. Chang HH, Chang YJ, Yeh CL, et al. Development of calcium phosphate/calcium sulfate biphasic biomedical material with hyaluronic acid containing collagenase and simvastatin for vital pulp therapy. Dental Materials 2020;36(6):755–764. DOI: 10.1016/j.dental.2020.03.018
PDF Share
PDF Share

© Jaypee Brothers Medical Publishers (P) LTD.